Falling sales, rising health consciousness, and growing awareness of alcohol’s harms are exposing deep flaws in Big Alcohol’s business model – dependent on heavy and high-risk alcohol use for large parts of profits. Multinational alcohol industry giants such as Diageo and Pernod Ricard are facing sharp profit declines, investor backlash, and eroding market confidence as consumers increasingly turn away from alcohol.
The alcohol industry responds to this crisis with aggressive marketing, lobbying, and expansion into developing countries with fewer alcohol policy protections for people and communities.
These trends reveal not resilience but vulnerability, creating a critical moment for policymakers to accelerate evidence-based alcohol policy action and protect people’s health.

Multinational Alcohol Giants Lose US$830 Billion As Alcohol Consumption Behaviours Change

A seismic shift is shaking the foundations of the global alcohol industry. Once seen as recession-proof, Big Alcohol is now under growing financial pressure as global alcohol use declines, health awareness rises, and consumers increasingly turn away from health-harming products.

According to a recent Bloomberg index tracking the world’s largest beer, wine, and liquor producers, more than US$830 billion in market value has evaporated since 2021 – a staggering 46% decline in just four years.

The world’s top alcohol corporations – including Diageo, Pernod Ricard, and Kweichow Moutai – are all seeing their once sky-high profits fall as investors question whether the alcohol industry’s traditional business model of driving ever-increasing alcohol consumption is losing its grip.

46%
Evaporating market value
More than US$830 billion in market value has evaporated since 2021 from the world’s largest beer, wine, and liquor producers – a staggering 46% decline in just four years.

The world’s biggest alcohol producers are facing mounting financial and structural challenges, exposing deep cracks in their long-touted growth strategies. In recent months, alcohol industry giants Diageo and Pernod Ricard have seen profits drop, shares tumble, and investor confidence waver as consumer behaviour shifts and market pressures intensify. These developments, reported by the Financial Times, Reuters, and Ad hoc News, reveal a broader industry reckoning, one that emphasises how changing lifestyles and growing awareness of alcohol’s harms are reshaping global markets.

The well-being movement and increasing public understanding of alcohol’s health risks have directly contributed to this shift in consumption behaviours and norms.

A Structural Shift in Alcohol Use Patterns

Analysts now agree that what’s happening is not a temporary dip – it’s a structural change.

This isn’t just a passing trend – we believe it’s a structural shift that’s set to reshape the beverage industry,” said Sarah Simon, Head of European Consumer Staples at Morgan Stanley, on the Morgan Stanley Thoughts on The Market podcast.

We see long term structural pressures that are starting to play out. There are three key factors behind this trend: increased moderation by younger [alcohol consumers], an ageing population, and then broader health and wellness trends.”

Sarah Simon, Head of European Consumer Staples, Morgan Stanley

The latest Gallup survey confirms this: alcohol use in the United States has dropped to its lowest level since records began in 1939.

Younger generations, in particular, are rejecting alcohol altogether. Health consciousness, the popularity of weight-loss drugs such as Ozempic, and the rise of cannabis and functional beverage alternatives are rapidly reshaping the market.

We’ve seen four times the impact of the financial crash on alcohol consumption,” said Barclays analyst Laurence Whyatt, according to Bloomberg reporting:

The market believes there’s been some sort of structural change and that we’re not going back to the growth rates we had in the past.”

Laurence Whyatt, analyst, Barclays

Health authorities are also shaping awareness. The World Health Organization’s clear stance that there is no safe level of alcohol use concerning cancer risk and growing recognition of alcohol as a Group 1 carcinogen are influencing public perception, especially among Millennials and Generation Z.

Stock Prices Collapse Across the Board

The financial strain is affecting Big Alcohol corporations across the industry:

  • Diageo, the world’s largest liquor producer, has seen its shares sink to a ten-year low after cutting sales and profit forecasts amid what its interim CEO called an “unsatisfactory” performance.
  • Pernod Ricard, the French alcohol conglomerate, is facing its worst downturn in a decade, with shares down nearly 20% from their recent peak.
  • Other Big Alcohol giants, Rémy Cointreau, Brown-Forman, and Treasury Wine Estates have each faced steep sales and share declines in 2025.
  • Even China’s baijiu giant Kweichow Moutai, once the world’s most valuable alcohol producer, is trading more than 40% below its 2021 high.

The problem, as analysts note, is both financial and cultural. Premium spirits – long the sector’s cash cow – are now falling victim to a generational shift that undermines Big Alcohol’s profit engine: high-volume, high-strength, and high-risk consumption.

Diageo: A Case Study in Decline and Disarray

At the center of the crisis stands Diageo, once the pride of the global alcohol industry.

In early November, Reuters reported that Diageo had cut its annual forecast after “unsatisfactory” results, with sales dropping sharply in the U.S. and China – its two biggest markets. The company now expects flat or lower sales through 2026, with only low single-digit profit growth.

The trouble runs deeper than numbers. Diageo has been mired in leadership turmoil since the sudden death of long-time CEO Ivan Menezes in 2023. His successor hailing from Big Tobacco, Debra Crew, resigned this July after losing the board’s confidence, amid speculation that Chief Financial Officer Nik Jhangiani was angling for her job. Jhangiani was then appointed interim CEO, but no permanent successor has been named – despite investor pressure and internal unrest.

Meanwhile, Diageo is cutting costs, selling assets, and warning investors about tariffs and falling U.S. spirits sales. Analysts say it’s an industry under siege – struggling to adapt as global alcohol use declines.

Diageo’s “Unsatisfactory” Performance and Investor Backlash

According to Reuters, Diageo, issued a profit warning that sent its shares to their lowest level in a decade. Sales of Diageo’s products in both the U.S. and China remaining weak. The U.S. market saw a 4.1% decline, particularly due to falling tequila sales, while China experienced double-digit declines as consumption of the local spirit baijiu dropped.

Diageo’s shares have already fallen 30% this year and dropped an additional 5.3% following the announcement, levels last seen in 2015.

Investors were also frustrated by the lack of an update on the appointment of a permanent CEO after Debra Crew’s abrupt departure in July. This uncertainty has raised doubts about the company’s strategic direction.

30%
Diageo Shares Tumble to Multi-Year Low
Diageo’s shares have already fallen 30% this year and dropped an additional 5.3% following the announcement of the profit warning, reaching levels last seen in 2015.

Pernod Ricard: The End of Premium Spirits Dominance?

Pernod Ricard is facing a similar reckoning.

As Ad Hoc News reported, the company’s share price has fallen by over 13% in the past year and nearly 20% from its peak, as its premiumisation strategy – once the industry’s gold standard – now faces steep headwinds.

Consumer demand for luxury spirits in China has weakened amid official alcohol bans at government functions, while cost-of-living pressures in Europe and North America are squeezing discretionary spending.

The company’s dividend payout offers temporary relief for investors, but analysts say the underlying fundamentals remain bleak.

The battle for consumer preference is intensifying,” the report concluded, “and the evidence suggests Pernod Ricard is currently falling behind.”

Ad Hoc News: “Pernod Ricard Shares: Is the Liquor Giant Losing Its Spirit?”

Pernod Ricard’s Declining Fortunes and Market Anxiety

The French alcohol conglomerate is enduring its most severe downturn in a decade, losing nearly 10% of its share value since the start of the year and over 13% in the past twelve months.

Even Pernod Ricard’s dividend payout of €4.70 per share, meant to reassure investors, has failed to mask structural weaknesses or revive optimism.

The company faces a confluence of factors, from eroding consumer sentiment in China to U.S. tariffs, higher interest rates, and rising production costs.

10%
Pernod Ricard Faces Sharp Share Decline
The company is enduring its most severe downturn in a decade, losing nearly 10% of its share value since the start of the year and over 13% in the past twelve months.

A Broken Business Model

Behind the glossy marketing and celebrity partnerships, the alcohol industry’s business model relies on one stark reality: most profits come from heavy and high-risk alcohol use.

Independent studies consistently show that the top 10% of alcohol users account for more than half of total sales in major markets such as the U.S., the U.K., and Australia. The less alcohol people consume and the more they reduce or quit – the more Big Alcohol’s profits erode.

That’s why the current global shift toward sober curiosity, alcohol-free living, and mindful, health conscious lifestyles is existential for Big Alcohol. It exposes how much the industry depends on unhealthy, unsustainable patterns of alcohol use to sustain its growth and profit thirst.

Industry-Wide Decline and Eroding Premium Market

These trends mirror the broader industry slowdown. According to Bloomberg, consumers in key global markets are cutting back on alcohol use as they prioritise health and financial stability. The premium alcohol segment, once a major profit driver, has been particularly hard hit. In China, for instance, government measures limiting alcohol use at official functions have reduced high-end sales. In Western markets, consumers are turning toward alcohol-free lifestyles.

According to research, these patterns are part of a long-term global shift in alcohol norms. People’s awareness about alcohol’s role in cancer, heart disease, and mental health problems has increased significantly, while more communities advocate for prevention-oriented policies and alcohol-free social spaces. In fact, research reports that more young people across the world are choosing to live free from alcohol, a major challenge to Big Alcohol’s traditional business model.

Aggressive Marketing and Lobbying Intensify

As profit margins tighten, the industry is responding with even more aggressive marketing, lobbying, and political interference.

Movendi’s Big Alcohol Exposed initiative and increasingly investigative journalists are revealing how alcohol multinationals coordinate lobbying efforts to delay cancer warning labels in Ireland, undermine and water down WHO alcohol policy resolutions, and derail national tax reforms.

Alcohol industry lobby groups such as the International Alliance for Responsible Drinking (IARD) – funded by the world’s largest alcohol corporations – are expanding their budgets and political operations, positioning themselves as “partners” in health while fighting evidence-based alcohol policy from behind the scenes.

At the same time, producers are pouring money into digital marketing that targets young audiences through influencers, gaming, and zero-alcohol brand extensions – products that serve primarily as brand marketing tools to keep alcohol logos visible and normalise alcohol use among new generations.

Big Alcohol’s Aggressive Pushback Amid Crisis

As profits shrink, alcohol corporations are responding with increasingly aggressive marketing strategies and lobbying efforts

1. Legal intimidation and denial of wrongdoing

As reported by The Spirits Business, Diageo filed motions in both New York and Florida to dismiss lawsuits claiming its Don Julio and Casamigos Tequilas were falsely marketed as “100% agave.” The company called the allegations “baseless,” discredited independent testing by the Additive Free Alliance, and attacked the credibility of the plaintiffs instead of addressing transparency concerns.

2. Lobbying against alcohol taxes and other evidence-based policy solutions

Alcohol companies campaign aggressively against higher alcohol duties with flawed and misleading claims. They also resist minimum pricing laws, advertising bans, and common sense limits on alcohol availability in countries.

3. Opposition to health warnings and WHO guidelines

Big Alcohol continues to lobby against cancer warning labels on bottles and WHO-endorsed guidelines. Companies pressure governments to delay or derail labeling laws, such as those introduced in Ireland.

4. Funding and promoting biased research

Alcohol corporations sponsor industry-friendly studies designed to downplay alcohol’s link to cancer, heart disease, and other health harms. This mirrors the tactics used by Big Tobacco to cast doubt on independent science.

5. Manipulative marketing and misinformation

Companies promote misleading ideas of “moderation” and “responsible drinking” to normalise alcohol use. These campaigns shift focus away from the need for alcohol policy to hold the alcohol industry accountable for the harms their products and practices cause and instead seek to frame alcohol consumption as a personal choice rather than a public health issue.

6. Targeting younger audiences through social media

With younger generations increasingly rejecting alcohol, companies use influencers, music festivals, and digital marketing to keep alcohol visible and appealing to youth, often blurring the line between entertainment and promotion.

7. Expansion into markets with weaker alcohol policies

As consumption declines in Western countries, Big Alcohol is aggressively expanding into Asia, Africa, and Latin America, where alcohol policy protections for people and communities are often less robust and developed. Marketing campaigns in these regions associate alcohol with modernity, freedom, and success, undermining local public health efforts.

8. Rebranding alcohol as part of a “healthy” lifestyle

In response to the popularity of weight-loss drugs like Ozempic and Wegovy and growing health awareness, Big Alcohol companies market “low-calorie” and “low-carb” products to appeal to fitness-conscious consumers while denying alcohol’s role in obesity and chronic disease.

9. Price manipulation and premiumisation strategies

To offset declining sales, companies are raising prices on “premium” products while offering discounts in price-sensitive markets, ensuring continued consumption despite economic hardship.

10. Undermining public health systems and policy advocacy

Industry groups attempt to weaken or delay evidence-based alcohol policies by influencing trade agreements, exploiting policy loopholes, and funding front groups that appear to represent public interests.

Investors Split: Value Play or Sinking Ship?

Some investors, such as the U.S. hedge fund Cook & Bynum, are betting the slump is cyclical – buying into emerging-market brewers such as Ambev and Backus, according to Bloomberg reporting:

We don’t think people are going to stop consuming alcohol,” said partner Richard Cook, betting on “premiumization” in developing economies.

Richard Cook, partner, U.S. hedge fund Cook & Bynum

But others see a long-term decline. As Bell Asset Management’s Andrew Gowen put it, as per Bloomberg:

Comparisons between the alcohol and tobacco industries would have been inconceivable five years ago. But declining volumes are forcing producers to cut costs and shift to cheaper options.”

Andrew Gowen, head of research, Bell Asset Management

The Bigger Picture: A Turning Point for Global Health and Policy

These recent developments show that Big Alcohol’s business model is under serious strain. Falling profits, declining investor confidence, and growing public awareness are converging to challenge the industry’s dominance. What once looked like a resilient market now reveals deep structural weaknesses. For communities and policymakers, this moment presents an opportunity to strengthen evidence-based alcohol prevention measures that protect people’s health and well-being while reducing the social and economic costs driven by alcohol use.

For public health advocates, the current market turmoil underscores a simple truth: when alcohol use declines, societies benefit – and the alcohol industry loses.

Reduced alcohol consumption translates into fewer cancers, injuries, and mental health conditions – and lower burdens on health systems. The challenge now is ensuring that governments resist industry lobbying and instead seize the opportunity to implement evidence-based policies such as higher taxation, comprehensive marketing regulation, commons sense alcohol availability limits, and health warnings.

Big Alcohol’s profit crisis reveals what health experts have long warned: the industry’s fortunes rise and fall on the extent of alcohol harm. The more the world wakes up to that fact, the clearer it becomes that the future of health needs public policy action to protect people from the alcohol industry’s predatory practices.


Sources

Bloomberg: “Alcohol Stocks Take $830 Billion Hit

Beverage Industry: “Premiumization trends span across beverage industry. Alcohol, non-alcohol brands experience effects of premiumization”

The Spirits Business: “Diageo doubles down on defence of ‘100% agave’ tequilas”

Reuters: “Diageo cuts outlook, sinking shares, after ‘unsatisfactory’ spell”

Financial Times: “Diageo battles investor disquiet on prolonged CEO search

Financial Times: “Diageo cuts sales and profit forecast on lower US and China demand. Guinness maker’s struggles come as company continues search for new chief executive”

Ad-Hoc-News: “Pernod Ricard shares: Is the liquor giant losing its spirit?”